AU5231186A - Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them - Google Patents
Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- AU5231186A AU5231186A AU52311/86A AU5231186A AU5231186A AU 5231186 A AU5231186 A AU 5231186A AU 52311/86 A AU52311/86 A AU 52311/86A AU 5231186 A AU5231186 A AU 5231186A AU 5231186 A AU5231186 A AU 5231186A
- Authority
- AU
- Australia
- Prior art keywords
- amino
- preparation
- pharmaceutical compositions
- compositions containing
- acid derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT23799A/84 | 1984-11-29 | ||
IT23799/84A IT1196348B (it) | 1984-11-29 | 1984-11-29 | Composti ad attivita'antiinfiammatoria |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5231186A true AU5231186A (en) | 1986-06-18 |
Family
ID=11210091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52311/86A Abandoned AU5231186A (en) | 1984-11-29 | 1985-11-26 | Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them |
Country Status (12)
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9017711D0 (en) * | 1990-08-13 | 1990-09-26 | May & Baker Ltd | New compositions of matter |
GB9017710D0 (en) * | 1990-08-13 | 1990-09-26 | May & Baker Ltd | New compositions of matter |
IT1244873B (it) * | 1990-09-12 | 1994-09-12 | Depha Team Srl | Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali |
US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
FR2738150B1 (fr) * | 1995-09-01 | 1997-10-31 | Synthelabo | Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux |
ES2226818T3 (es) * | 2000-04-19 | 2005-04-01 | Neurotech Co., Ltd. | Compuestos, composiciones y metodos para prevenir la neurodegeneracion y daños cronicos en el sistema nervioso central. |
US6964982B2 (en) | 2000-04-20 | 2005-11-15 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
NO20013534L (no) * | 2000-07-18 | 2002-01-21 | Koyo Chemical Company Ltd | Anvendelse av en blanding omfattende et glucosaminsalt eller et glucosaminderivat for fremstilling av et medikament for behandling av human trombose |
DE60141725D1 (de) | 2001-01-19 | 2010-05-12 | Apex Biotechnology Corp | Nicht enzymatischer Einwegerkennungselektrodenstreifen der einen oberflächenaktiven Stoff beinhaltet, zum Nachweis von Harnsäure; Herstellungsverfahren dafür und Verwendung davon |
KR20040048411A (ko) | 2001-09-14 | 2004-06-09 | 메틸진, 인크. | 히스톤 데아세틸라아제의 억제제 |
AU2003245070C1 (en) | 2002-06-19 | 2008-02-28 | GNT Pharma Co., Ltd | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
KR100668111B1 (ko) | 2005-07-28 | 2007-01-12 | (주)에스에이치제약 | 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법 |
AU2007239191B2 (en) | 2006-04-13 | 2010-10-28 | Neurotech Pharmaceuticals Co., Ltd. | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
CN100422721C (zh) * | 2006-05-26 | 2008-10-01 | 南京大学 | 一种利用糖基萘酚的铝离子检测方法 |
KR20100097113A (ko) * | 2007-10-23 | 2010-09-02 | 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 | Pai-1 생산 억제제 |
KR100852962B1 (ko) | 2007-11-12 | 2008-08-20 | 주식회사 뉴로테크 | 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법 |
SG192488A1 (en) * | 2008-07-08 | 2013-08-30 | Catabasis Pharmaceuticals Inc | Fatty acid acetylated salicylates and their uses |
US9085527B2 (en) | 2008-07-08 | 2015-07-21 | Catabasis Pharmaceuticals, Inc. | Fatty acid acylated salicylates and their uses |
KR101204108B1 (ko) * | 2009-02-09 | 2012-11-22 | 주식회사 지엔티파마 | 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도 |
NZ599067A (en) | 2009-09-01 | 2014-04-30 | Catabasis Pharmaceuticals Inc | Fatty acid niacin conjugates and their uses |
USRE46608E1 (en) | 2009-09-01 | 2017-11-14 | Catabasis Pharmaceuticals, Inc. | Fatty acid niacin conjugates and their uses |
JP6202287B2 (ja) * | 2012-05-23 | 2017-09-27 | セリックスビオ プライヴェート リミテッド | 炎症性腸疾患の治療のための組成物及び方法 |
WO2014070859A1 (en) * | 2012-10-30 | 2014-05-08 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Stat3 dimerization inhibitors |
KR20210107828A (ko) * | 2018-12-28 | 2021-09-01 | 주식회사 지엔티파마 | 신경퇴행성 질환 치료를 위한 조성물 및 방법 |
CN111116395B (zh) * | 2019-12-27 | 2023-04-07 | 湖北工业大学 | 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR4546M (enrdf_load_stackoverflow) * | 1964-06-09 | 1966-11-02 | ||
NL7008623A (enrdf_load_stackoverflow) * | 1969-06-25 | 1970-12-29 | ||
JPS5640710B2 (enrdf_load_stackoverflow) * | 1973-01-18 | 1981-09-22 | ||
JPS6056130B2 (ja) * | 1978-03-20 | 1985-12-09 | 久光製薬株式会社 | 新規なサリチル酸誘導体 |
US4536346A (en) * | 1983-05-06 | 1985-08-20 | American Cyanamid Company | Aralkanamidophenyl compounds |
-
1984
- 1984-11-29 IT IT23799/84A patent/IT1196348B/it active
-
1985
- 1985-11-25 GR GR852834A patent/GR852834B/el unknown
- 1985-11-26 JP JP61500163A patent/JPS62501703A/ja active Pending
- 1985-11-26 ZA ZA859035A patent/ZA859035B/xx unknown
- 1985-11-26 AU AU52311/86A patent/AU5231186A/en not_active Abandoned
- 1985-11-26 EP EP86900097A patent/EP0236329A1/en not_active Withdrawn
- 1985-11-26 WO PCT/EP1985/000645 patent/WO1986003199A1/en not_active Application Discontinuation
- 1985-11-27 CN CN198585109554A patent/CN85109554A/zh active Pending
- 1985-11-27 PT PT81566A patent/PT81566B/pt unknown
- 1985-11-28 ES ES549359A patent/ES8701717A1/es not_active Expired
-
1986
- 1986-07-21 DK DK346486A patent/DK346486D0/da not_active Application Discontinuation
- 1986-07-28 KR KR1019860700507A patent/KR870700608A/ko not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
IT8423799A0 (it) | 1984-11-29 |
DK346486A (da) | 1986-07-21 |
GR852834B (enrdf_load_stackoverflow) | 1986-03-27 |
DK346486D0 (da) | 1986-07-21 |
EP0236329A1 (en) | 1987-09-16 |
ES8701717A1 (es) | 1986-12-01 |
ZA859035B (en) | 1986-08-27 |
PT81566B (en) | 1987-04-07 |
KR870700608A (ko) | 1987-12-30 |
JPS62501703A (ja) | 1987-07-09 |
CN85109554A (zh) | 1986-07-23 |
ES549359A0 (es) | 1986-12-01 |
PT81566A (en) | 1985-12-01 |
WO1986003199A1 (en) | 1986-06-05 |
IT1196348B (it) | 1988-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5231186A (en) | Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them | |
PT86366A (en) | Process for the preparation of phosphinic acid derivatives and of pharmaceutical compositions containing the same | |
IL76453A (en) | Isoxazolecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
HUT43825A (en) | Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them | |
HUT48902A (en) | Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
IL74826A (en) | 3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
PH20703A (en) | Quinolinecarboxylic acid derivatives process for their preparation and pharmaceutical composition containing them | |
HUT40639A (en) | Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them | |
PT83565A (en) | Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same | |
IL77849A0 (en) | Aryldihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them | |
AU537560B2 (en) | Phenyl-alkanoic acid derivatives and their preparation and pharmaceutical compositions containing them | |
HUT41801A (en) | Process for producing new cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them | |
HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
IL75603A0 (en) | 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
IL75913A0 (en) | Phenyl-nonatetraenoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
SG59992G (en) | Dihydroorotic acid derivatives,processes for their preparing and pharmaceutical composition containing them | |
ZA864504B (en) | Derivatives of 2-fluoroalkylbenzimidazole,process for their preparation and pharmaceutical compositions containing them | |
IL80679A (en) | 16,17-acetalsubstituted pregnane 21-oic acid derivatives,process for their preparation and pharmaceutical compositions containing them | |
PT80799B (en) | Aminoeburnanecarboxylic acid derivatives pharmaceutical compositions containing them and process for preparing same | |
AU578104B2 (en) | Pharmaceutical composition of peroxydiphosphoric acid derivatives | |
DE3661070D1 (en) | 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them | |
PT80800A (en) | Nitroapovincaminic acid derivatives pharmaceutical compositions containing them and process for preparing same | |
IL77799A0 (en) | Dihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them | |
IL89836A0 (en) | Penicilanic acid derivatives,process for their preparation and pharmaceutical compositions containing them | |
IL69105A0 (en) | Apovincaminic acid derivatives,process for their preparation and pharmaceutical compositions containing them |